Table 3 Laboratory and MRI monitoring of interferon beta patients according to the German competence network multiple sclerosis (KKNMS) [52]
Prior to IFN initiation | During IFN treatment | |||
|---|---|---|---|---|
After 1 month of initiation | Quarterly during first year of treatment | 1 year of initiation: every 6–12 months or as clinically indicated | ||
Complete, differential blood cell & platelet counts | x | x | x | x |
Liver enzyme tests (ALT, AST, GGT, bilirubin) | x | x | x | x |
Renal function (creatinine, estimated creatinine clearance/GFR) | x | x | x | x |
Inflammation and Infections (urine status) | x | |||
TSH | periodically | |||
Pregnancy test | x | |||
MRI | x | annually | ||